| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000037658 |
| Receipt No. | R000042944 |
| Scientific Title | Comparison and examination of standard method and two cup one cup method of oral enteral lavage in colonoscopy |
| Date of disclosure of the study information | 2019/08/22 |
| Last modified on | 2019/08/10 (Ver. 1) |
| Basic information | ||
| Public title | Comparison and examination of standard method and two cup one cup method of oral enteral lavage in colonoscopy | |
| Acronym | Comparison and examination of standard method and two cup one cup method of oral enteral lavage in colonoscopy | |
| Scientific Title | Comparison and examination of standard method and two cup one cup method of oral enteral lavage in colonoscopy | |
| Scientific Title:Acronym | Comparison and examination of standard method and two cup one cup method of oral enteral lavage in colonoscopy | |
| Region |
|
|
| Condition | |||
| Condition | Gastroenterology outpatients undergoing colonoscopy | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | We will compare and consider the taking method (standard method and two cups method) so that patients can take oral intestinal cleanser used for pretreatment of colonoscopy without pain. |
| Basic objectives2 | Others |
| Basic objectives -Others | By comparing and examining how to take the oral intestinal cleanser used in colonoscopy, it becomes a pretreatment that can alleviate the pain and anxiety of the patient. |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Ease of drinking Movi prep (taste, amount, water consumption)
Comprehension of how to medication |
| Key secondary outcomes | Cleaning effect evaluation
Mobiprep dose Water consumption |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | YES |
| Dynamic allocation | NO |
| Institution consideration | Institution is considered as a block. |
| Blocking | YES |
| Concealment | Pseudo-randomization |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Standard method for oral intestinal cleanser | |
| Interventions/Control_2 | two cup one cup methodfor oral intestinal cleanser | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Gastroenterological outpatients undergoing colonoscopy and patients with consent | |||
| Key exclusion criteria | Person who can not obtain consent | |||
| Target sample size | 480 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Aoyama General Hospital | ||||||
| Division name | Outpatient | ||||||
| Zip code | 441-0195 | ||||||
| Address | 100-1, Doji Kozakai, Toyokawa, Aichi,Japan | ||||||
| TEL | +81-533-73-3777 | ||||||
| gairai@aoyama-hp.or.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Aoyama General Hospital | ||||||
| Division name | Outpatient | ||||||
| Zip code | 441-0195 | ||||||
| Address | 100-1, Doji Kozakai, Toyokawa, Aichi,Japan | ||||||
| TEL | +81-533-73-3777 | ||||||
| Homepage URL | |||||||
| cnic-kato@aoyama-hp.or.jp | |||||||
| Sponsor | |
| Institute | Aoyama General Hospital
Nursing department |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Aoyama General Hospital
Nursing department |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Aoyama General Hospital Ethics Committee |
| Address | 100-1, Doji Kozakai, Toyokawa, Aichi,Japan |
| Tel | +81-533-73-3777 |
| ijika@aoyama-hp.or.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 総合青山病院(愛知県)
Aoyama General Hospital (Aichi) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042944 |